Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
2,923,081
-
Share change
-
+2,122,260
-
Total reported value
-
$8,225,000
-
Price per share
-
$2.80
-
Number of holders
-
17
-
Value change
-
+$5,984,181
-
Number of buys
-
12
-
Number of sells
-
2
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2020
As of 31 Mar 2020 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,923,081 shares of stock of the company.
Largest 10 holders included Stonepine Capital Management, LLC, Nantahala Capital Management, LLC, Granite Point Capital Management, L.P., Manatuck Hill Partners, LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, and NORTHERN TRUST CORP.
This table shows 18 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.